top of page

Management Structure

Inno4Vac is divided into 4 subtopics and 21 Work Packages (WP), including WP dedicated to ethics, consortium management and communications. Each subtopic is led by a public and a private partner.  

​

The Inno4Vac governance is a multi-layered structure composed of the following bodies:  

  • General Assembly (GA) 

  • Steering Committee (SC) 

  • Coordination and Scientific Management Team (CSMT)  

  • Scientific and Ethics Advisory Committee (SEAC) 

 

The Project Coordinator (EVI) is responsible for the administration and coordination of the consortium. The Industry leader (GSK) and Industry co-leader (SP) supervise and drive the project, ensuring that the industry’s needs, vision and expectations are always taken into account. The Scientific Coordinator (SVA), aligned with the Coordinator and Industry Leader and Co-Leader, is responsible to coordinate the design of the scientific project tasks, oversee the scientific progress of the project, coordinate the scientific activity of the project teams, ensuring that expectations and needs of academic partners and SMEs are adequately addressed. The Project Secretariat is the project management team gathering multiple expertise required to ensure a good and successful operational management of the project. 

Governance Process.png
  • LinkedIn
  • Twitter
  • YouTube

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101007799 (Inno4Vac). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Funder Aknowledgment.png

This communication reflects the authors' view(s) and that neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.

© 2023 European Vaccine Initiative. Designed by European Vaccine Initiative.

bottom of page